Replies to post #10946 on CryoPort Inc (CYRX)

[coldasice]

Laser,

“The industry anticipates several commercial filings and/or launches during the current year, which include Kite’s KTE-C19, Spark Therapeutics’ Voretigene Neparvovec, Novartis’ CTL-019, TiGenix’s Cx601, and Kiadis Pharma’s ATIR101, many of which Cryoport is actively supporting. . .

We know that Kite and NVS are completed. Sparks/Voretigene are connected, CYRX customer? TiGenix is definitely a CYRX customer, they're close.. Kiadis?
Hyper presented the Juno news, my money is on Bluebird Bio to file soon..
ASCO in about 2 weeks or so.. JUNO, BLUE, NVS and BLCM high lighted as part of top 8 to watch..
Let's not forget, NVS 2nd indication..